Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
Authors
Bubendorf, LDafni, U
Schöbel, M
Finn, S
Tischler, V
Sejda, A
Marchetti, A
Thunnissen, E
Verbeken, E
Warth, A
Sansano, I
Cheney, R
Speel, E
Nonaka, Daisuke
Monkhorst, K
Hager, H
Martorell, M
Savic, S
Kerr, K
Tan, Q
Tsourti, Z
Geiger, T
Kammler, R
Schulze, K
Das-Gupta, A
Shames, D
Peters, S
Stahel, R
Affiliation
Institute of Pathology, University Hospital Basel, Basel, SwitzerlandIssue Date
2017-09
Metadata
Show full item recordAbstract
In a well-defined NSCLC cohort of the ETOP Lungscape program, we explored the epidemiology of IHC MET overexpression and amplification, their inter-correlation, and their association to outcome.Citation
Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. 2017, 111:143-149 Lung CancerJournal
Lung CancerDOI
10.1016/j.lungcan.2017.07.021PubMed ID
28838386Type
ArticleLanguage
enISSN
1872-8332ae974a485f413a2113503eed53cd6c53
10.1016/j.lungcan.2017.07.021
Scopus Count
Collections
Related articles
- Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.
- Authors: Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S, ETOP Lungscape Consortium.
- Issue date: 2018 Jan 1
- Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification.
- Authors: Weingertner N, Meyer N, Voegeli AC, Guenot D, Renaud S, Massard G, Falcoz PE, Olland A, Mennecier B, Gaub MP, Lindner V, Ghnassia JP, Quoix E, Chenard MP, Beau-Faller M
- Issue date: 2015 Jun
- Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer.
- Authors: Saigi M, McLeer-Florin A, Pros E, Nadal E, Brambilla E, Sanchez-Cespedes M
- Issue date: 2018 Jul
- The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
- Authors: Al-Saad S, Richardsen E, Kilvaer TK, Donnem T, Andersen S, Khanehkenari M, Bremnes RM, Busund LT
- Issue date: 2017
- Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer.
- Authors: Dziadziuszko R, Wynes MW, Singh S, Asuncion BR, Ranger-Moore J, Konopa K, Rzyman W, Szostakiewicz B, Jassem J, Hirsch FR
- Issue date: 2012 Feb